Apogee Therapeutics, Inc. APGE Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apogee Therapeutics, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Apogee Therapeutics, Inc.'s net change in cash?
- Apogee Therapeutics, Inc. (APGE) reported net change in cash of $320.25M in Q1 2026.
- How has Apogee Therapeutics, Inc.'s net change in cash changed year-over-year?
- Apogee Therapeutics, Inc.'s net change in cash increased by 1018.3% year-over-year, from -$34.87M to $320.25M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.